2023
DOI: 10.1186/s12936-023-04578-3
|View full text |Cite
|
Sign up to set email alerts
|

Adherence to 14-day radical cure for Plasmodium vivax malaria in Papua, Indonesia: a mixed-methods study

Abstract: Background Reducing the risk of recurrent Plasmodium vivax malaria is critical for malaria control and elimination. Primaquine (PQ) is the only widely available drug against P. vivax dormant liver stages, but is recommended as a 14-day regimen, which can undermine adherence to a complete course of treatment. Methods This is a mixed-methods study to assess socio-cultural factors influencing adherence to a 14-day PQ regimen in a 3-arm, treatment effe… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 41 publications
(47 reference statements)
0
1
0
Order By: Relevance
“…The radical cure for P. vivax malaria requires a 14-day primaquine (PQ) treatment to eliminate hypnozoites in the human liver [ 4 ]. However, patients’ compliance with such a regimen is a major challenge [ 5 , 6 ]. According to a recent report, approximately 20% of malaria cases presented recurrent or relapse episodes, most of which occurring within 1 year after the initial infection [ 7 ].…”
Section: Introductionmentioning
confidence: 99%
“…The radical cure for P. vivax malaria requires a 14-day primaquine (PQ) treatment to eliminate hypnozoites in the human liver [ 4 ]. However, patients’ compliance with such a regimen is a major challenge [ 5 , 6 ]. According to a recent report, approximately 20% of malaria cases presented recurrent or relapse episodes, most of which occurring within 1 year after the initial infection [ 7 ].…”
Section: Introductionmentioning
confidence: 99%